KardiaMobile 6L for measuring QT interval in people having antipsychotic medication to inform early value assessment: a systematic review

Background The indication for this assessment is the use of the KardiaMobile six-lead electrocardiogram device for the assessment of QT interval-based cardiac risk in service users prior to the initiation of, or for the monitoring of, antipsychotic medications, which are associated with an establish...

Full description

Bibliographic Details
Main Authors: Marie Westwood, Nigel Armstrong, Pawel Posadzki, Caro Noake
Format: Article
Language:English
Published: NIHR Journals Library 2024-03-01
Series:Health Technology Assessment
Subjects:
Online Access:https://doi.org/10.3310/TFHU0078